SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 183 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | +36.4% | 34,208 | +134.4% | 0.00% | – |
| Q2 2022 | $11,000 | -82.0% | 14,596 | -44.2% | 0.00% | – |
| Q1 2020 | $61,000 | -47.4% | 26,172 | +96.8% | 0.00% | -100.0% |
| Q4 2018 | $116,000 | -96.3% | 13,300 | -92.9% | 0.00% | -91.7% |
| Q3 2018 | $3,152,000 | +101.8% | 187,671 | +93.3% | 0.01% | +71.4% |
| Q1 2018 | $1,562,000 | – | 97,068 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
| ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
| NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
| Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
| Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
| Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
| J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
| J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
| Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |